These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22922569)

  • 1. Focus.
    Friedman SL
    J Hepatol; 2012 Nov; 57(5):935-6. PubMed ID: 22922569
    [No Abstract]   [Full Text] [Related]  

  • 2. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
    Nakamura K; Hatano E; Narita M; Miyagawa-Hayashino A; Koyama Y; Nagata H; Iwaisako K; Taura K; Uemoto S
    J Hepatol; 2012 Nov; 57(5):1037-43. PubMed ID: 22796153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are Hedgehog and Wnt/β-catenin pathways involved in hepatitis C virus-mediated EMT?
    Conti B; Minutolo A; Arciello M; Balsano C
    J Hepatol; 2013 Mar; 58(3):636-7. PubMed ID: 23195619
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to: "Are Hedgehog and Wnt/β-catenin pathways involved in hepatitis C virus-mediated EMT?": persistent activation of Hedgehog or Wnt/β-catenin pathways is not involved in EMT mediated by HCV NS5A protein.
    Grégoire D; Akkari L; Carenco C; Hibner U
    J Hepatol; 2013 Mar; 58(3):637-8. PubMed ID: 23201238
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C viral protein NS5A induces EMT and participates in oncogenic transformation of primary hepatocyte precursors.
    Akkari L; Grégoire D; Floc'h N; Moreau M; Hernandez C; Simonin Y; Rosenberg AR; Lassus P; Hibner U
    J Hepatol; 2012 Nov; 57(5):1021-8. PubMed ID: 22750466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-to-Mesenchymal Transition: A Mediator of Sorafenib Resistance in Advanced Hepatocellular Carcinoma.
    Mir N; Jayachandran A; Dhungel B; Shrestha R; Steel JC
    Curr Cancer Drug Targets; 2017; 17(8):698-706. PubMed ID: 28460616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
    Deng YR; Liu WB; Lian ZX; Li X; Hou X
    Oncotarget; 2016 Jun; 7(25):38292-38305. PubMed ID: 27203677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial-mesenchymal transition and fibroblast activation.
    Chen YL; Zhang X; Bai J; Gai L; Ye XL; Zhang L; Xu Q; Zhang YX; Xu L; Li HP; Ding X
    Cell Death Dis; 2013 Jun; 4(6):e665. PubMed ID: 23764846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted treatment of ovarian cancer--the multiple - kinase - inhibitor sorafenib as a potential option.
    Smolle E; Taucher V; Petru E; Haybaeck J
    Anticancer Res; 2014 Apr; 34(4):1519-30. PubMed ID: 24692678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorafenib is effective in the treatment of pulmonary veno-occlusive disease.
    Kataoka M; Yanagisawa R; Fukuda K; Yoshino H; Satoh T
    Cardiology; 2012; 123(3):172-4. PubMed ID: 23128832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
    Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
    J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the hepatic veno-occlusive disease models induced by gynura segetum, monocrotaline and cyclophosphamide].
    Yang L; Zhu HY; Chen Z; Huo JR
    Zhonghua Gan Zang Bing Za Zhi; 2010 Dec; 18(12):944-5. PubMed ID: 21205486
    [No Abstract]   [Full Text] [Related]  

  • 13. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
    Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
    Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib.
    Deng YR; Ma HD; Tsuneyama K; Yang W; Wang YH; Lu FT; Liu CH; Liu P; He XS; Diehl AM; Gershwin ME; Lian ZX
    J Autoimmun; 2013 Oct; 46():25-34. PubMed ID: 23948302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New knowledge of the mechanisms of sorafenib resistance in liver cancer.
    Zhu YJ; Zheng B; Wang HY; Chen L
    Acta Pharmacol Sin; 2017 May; 38(5):614-622. PubMed ID: 28344323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma.
    Chen J; Jin R; Zhao J; Liu J; Ying H; Yan H; Zhou S; Liang Y; Huang D; Liang X; Yu H; Lin H; Cai X
    Cancer Lett; 2015 Oct; 367(1):1-11. PubMed ID: 26170167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic sesamol attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats by inhibiting matrix metalloproteinase-9.
    Periasamy S; Hsu DZ; Chen SY; Yang SS; Chandrasekaran VR; Liu MY
    Cell Biochem Biophys; 2011 Nov; 61(2):327-36. PubMed ID: 21681587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?
    Faivre S; de Gramont A; Raymond E
    Target Oncol; 2016 Aug; 11(4):565-7. PubMed ID: 26996978
    [No Abstract]   [Full Text] [Related]  

  • 19. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
    Ezzat T; van den Broek MA; Davies N; Dejong CH; Bast A; Malagó M; Dhar DK; Olde Damink SW
    J Surg Oncol; 2012 Jul; 106(1):72-8. PubMed ID: 22287334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
    Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
    Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.